Insights

Benchmark International Successfully Facilitated the Transaction Between Precise Bioscience, LLC and New Horizon Medical Solutions

May 14, 2026

Precise Bioscience was founded in 2018 and is headquartered in Durham, North Carolina. As a global leader in wound care and sports medicine, Precise Bioscience offers a variety of advanced products built on lyophilized amniotic membrane technology. The company enables physicians to provide optimal patient outcomes through innovative allograft solutions that support regenerative healing by harnessing the body’s natural restorative capabilities.

“The acquisition by New Horizon validates the strength of the product portfolio we built from day one,” said Nate Schipper, founder of Precise Bioscience. “We couldn’t ask for a better partner to advance these products and deliver measurable impact for patients and providers alike.”

Unlock the Future of Your Business Today!

Founded in 2019 and headquartered in Las Vegas, NV, New Horizon Medical Solutions has established itself as a leading provider in the biologics wound care market through its innovative approach, process, and product offerings. The company focuses on delivering practice optimization services, full-practice billing, and best-in-class biologics products designed to enhance patient outcomes while reducing the total cost of care.

“We are thrilled to partner with a leader like Precise Bioscience, whose innovative technology enhances our ability to deliver superior patient care,” said Will Hall, Founder and CEO at New Horizon Medical Solutions. “Together, we will empower healthcare providers with products that accelerate healing, reduce complications, and improve the patient experience.”

This acquisition strengthens New Horizon Medical Solution’s position in the biologics wound care market by expanding its product portfolio and enhancing its ability to support healthcare providers with innovative regenerative healing solutions.

"It was a pleasure representing Precise Bioscience through this process. Their innovative regenerative medicine products and commitment to improving patient outcomes made them a standout business in the market, and we wish both parties continued success!"

- Sunny Garten, Senior Deal Associate at Benchmark International

Schedule a Call

Share This Post
Categories

Get These Insights Delivered Directly To Your Email

Explore our curated collection today and stay ahead of the curve in M&A.

Related Posts
Not Finding What You're Looking For?
Ready to dive into our featured M&A content and gain valuable insights for your business?